All News

Your patients are using herbal products, but do you know enough about them?

In a stock deal, Albertsons will buy the parts of Rite Aid that Walgreens didn't buy.

Up to 30% of the population is affected by the problem, this peer-reviewed article will give you the information you need.

In an effort to combat opioids, the FDA is pushing blister packs-something pharmacy groups have been advocating for.

Learning more about popular dietary supplements could further cement pharmacists’ position in the healthcare industry, helping them gain recognition as healthcare providers.

When natural doesn't always mean safe, and reading labels doesn't necessarily protect consumers.

Pharmacy groups are praising new Medicare Part D opioid limits.

Duggan named CEO at FIP

When it comes to cardiac disease, pharmacists in all practice settings can make a difference.

The DOAC edoxaban can replace dalteparin for treating cancer patients with venous thromboembolism.

The chain patented new tech to help better manage oncolytic usage.

Hurdles to adoption of biosimilars include regulatory issues and lack of interchangeability with the reference drugs.

Will healthcare manufacturing in Puerto Rico be back on its feet by next hurricane season?

New study finds just how much people like and trust their pharmacists.

Pharmacists need to stay informed about new technologies in order to help diabetic patients take advantage.

Research finds that pharmacists in ACOs improve medication use (and save money).

Easy-to-swallow bits of information from around the world of pharmacy.

Pharmacy chains are stepping up to help diabetes patients.

The pharmacist's role in diabetes care will only continue to grow.

New plans are designed around feedback and a desire to increase safety checks.

The Father of Vitamins was an incredibly important person who went unthanked-just like pharmacists.

How a gel could prevent opioid abuse and get pharmacists more involved.

An Australian study found that crush-proof opioids are working.

Over 450 hospitals have joined together over frustrations about drug prices and shortages.

Drug Topics asked PTCB CEO William Schimmel where the pharmacy technician profession is headed.

CMS is considering big changes to DIR fees and pharmacists are excited.

Vabomere combines a carbapenem and a beta-lactamase inhibitor as a treatment for complicated urinary tract infections.